NUZ 5.26% 20.0¢ neurizon therapeutics limited

PharmAust ready to trial monepantel on humans to fight motor neurone disease, page-30

  1. 747 Posts.
    lightbulb Created with Sketch. 1558
    Throughout the interview, it looked to me like Roger was a) pretty tired; and b) being VERY careful about what he said.

    The "other factors...now" comment I believe is vitally important. He's not saying "But we've decided to see if we can rustle up some interest in helping with/shaping the Phase 3." That's in the rear vision mirror now. Nope, this is something tangible that's caused a reconsideration of the trialling strategy that would involve a major player and a licensing agreement - Roger says as much later in the video. And it's happened pretty recently.

    Baby steps, but meaningful steps nonetheless.
    Last edited by Densy: 07/06/22
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $86.20K 429.7K

Buyers (Bids)

No. Vol. Price($)
3 67508 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 36444 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.